• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274/Pdl-1 expression.致癌物诱导的FVB小鼠品系膀胱癌与腺性分化及Cd274/Pdl-1表达增加有关。
Am J Clin Exp Urol. 2019 Jun 15;7(3):139-152. eCollection 2019.
2
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.致癌物诱导肿瘤的同基因模型模拟了肌层浸润性膀胱癌的基底/鳞状、富含基质和神经内分泌分子及免疫特征。
Front Oncol. 2023 Feb 3;13:1120329. doi: 10.3389/fonc.2023.1120329. eCollection 2023.
3
High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.p53(+/-)基因敲除小鼠在N-丁基-N-(4-羟丁基)亚硝胺诱导的膀胱癌发生过程中具有高度易感性,且残留等位基因中无频繁突变。
Cancer Res. 1998 Sep 1;58(17):3806-11.
4
The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice.BBN 诱导的小鼠膀胱癌发生过程中炎症反应的动力学。
J Transl Med. 2019 Nov 28;17(1):394. doi: 10.1186/s12967-019-02146-5.
5
N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.N-丁基-N-(4-羟丁基)亚硝胺诱导C57BL/6 X DBA/2 F1小鼠发生膀胱癌,作为用类维生素A进行癌症化学预防研究的有用模型。
Cancer Res. 1981 Mar;41(3):927-32.
6
Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer.衰老的小鼠膀胱中的性别差异及其对致癌物诱导膀胱癌模型肿瘤免疫微环境的影响。
Biol Sex Differ. 2022 May 3;13(1):19. doi: 10.1186/s13293-022-00428-0.
7
BBN-driven urinary bladder cancer mouse model.BBN 驱动的膀胱癌小鼠模型。
Methods Cell Biol. 2021;163:77-92. doi: 10.1016/bs.mcb.2020.10.020. Epub 2020 Nov 25.
8
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.塞来昔布可抑制雄性B6D2F1小鼠和雌性Fischer-344大鼠中由N-丁基-N-(4-羟基丁基)-亚硝胺诱导的膀胱癌。
Cancer Res. 2000 Oct 15;60(20):5599-602.
9
Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.N-丁基-N-(4-羟丁基)亚硝胺的组织特异性诱变作为尿路上皮癌发生的基础。
Mutat Res. 2012 Feb 18;742(1-2):92-5. doi: 10.1016/j.mrgentox.2011.11.015. Epub 2011 Dec 4.
10
Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.水飞蓟素和水飞蓟宾对N-丁基-N-(4-羟基丁基)亚硝胺诱导的雄性ICR小鼠膀胱癌发生的化学预防作用。
Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3248-55. doi: 10.1158/1535-7163.MCT-07-2006.

引用本文的文献

1
Interferon-γ/Janus Kinase 1/STAT1 Signaling Represses Forkhead Box A1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer.干扰素-γ/Janus激酶1/信号转导和转录激活因子1信号通路抑制叉头框A1并驱动肌层浸润性膀胱癌的基础转录状态。
Am J Pathol. 2025 May;195(5):1013-1030. doi: 10.1016/j.ajpath.2025.01.013. Epub 2025 Feb 20.
2
Preclinical models of bladder cancer: BBN and beyond.膀胱癌的临床前模型:BBN 及其他。
Nat Rev Urol. 2024 Dec;21(12):723-734. doi: 10.1038/s41585-024-00885-9. Epub 2024 May 20.
3
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.致癌物诱导肿瘤的同基因模型模拟了肌层浸润性膀胱癌的基底/鳞状、富含基质和神经内分泌分子及免疫特征。
Front Oncol. 2023 Feb 3;13:1120329. doi: 10.3389/fonc.2023.1120329. eCollection 2023.
4
The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool For Ovarian Cancer Immunotherapy Research.小鼠卵巢癌模型的肿瘤免疫特征:卵巢癌免疫治疗研究的重要工具。
Cancer Res Commun. 2022 Jun;2(6):417-433. doi: 10.1158/2767-9764.crc-22-0017. Epub 2022 Jun 9.
5
Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.hsa-miR-570-3p 通过靶向 CD274 阻断 PI3K/AKT/mTOR 信号通路对三阴性乳腺癌的保护作用。
Kaohsiung J Med Sci. 2020 Aug;36(8):581-591. doi: 10.1002/kjm2.12212. Epub 2020 Apr 20.

本文引用的文献

1
Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants.膀胱癌的分子亚型和组织学变异的肿瘤内异质性。
Eur Urol. 2019 Jan;75(1):18-22. doi: 10.1016/j.eururo.2018.09.003. Epub 2018 Sep 25.
2
Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy.高级别尿路上皮癌的分子亚型特异性免疫活性模型揭示了不同的新生抗原表达和对免疫治疗的反应。
Cancer Res. 2018 Jul 15;78(14):3954-3968. doi: 10.1158/0008-5472.CAN-18-0173. Epub 2018 May 21.
3
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.NCCN 指南解读:霍奇金淋巴瘤,第 1.2018 版。
J Natl Compr Canc Netw. 2018 Mar;16(3):245-254. doi: 10.6004/jnccn.2018.0013.
4
A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.一种致癌剂诱导的小鼠模型重现了人类肌肉浸润性膀胱癌的分子改变。
Oncogene. 2018 Apr;37(14):1911-1925. doi: 10.1038/s41388-017-0099-6. Epub 2018 Jan 25.
5
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
6
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.肌层浸润性膀胱癌的综合分子特征分析
Cell. 2017 Oct 19;171(3):540-556.e25. doi: 10.1016/j.cell.2017.09.007. Epub 2017 Oct 5.
7
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.肌层浸润性膀胱癌分子亚型对新辅助化疗后反应和生存预测的影响。
Eur Urol. 2017 Oct;72(4):544-554. doi: 10.1016/j.eururo.2017.03.030. Epub 2017 Apr 5.
8
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.纳武利尤单抗单药治疗复发性转移性尿路上皮癌(CheckMate 032):一项多中心、开放标签、两阶段、多臂1/2期试验。
Lancet Oncol. 2016 Nov;17(11):1590-1598. doi: 10.1016/S1470-2045(16)30496-X. Epub 2016 Oct 9.
9
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.抗程序性细胞死亡配体-1免疫检查点抑制剂度伐利尤单抗(MEDI4736)在晚期尿路上皮膀胱癌患者中的安全性和有效性
J Clin Oncol. 2016 Sep 10;34(26):3119-25. doi: 10.1200/JCO.2016.67.9761. Epub 2016 Jun 6.
10
Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.尿路上皮膀胱癌中非 T 细胞炎症肿瘤微环境的分子驱动因素。
Cancer Immunol Res. 2016 Jul;4(7):563-8. doi: 10.1158/2326-6066.CIR-15-0274. Epub 2016 May 17.

致癌物诱导的FVB小鼠品系膀胱癌与腺性分化及Cd274/Pdl-1表达增加有关。

Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274/Pdl-1 expression.

作者信息

Amponsa Vasty Osei, Shuman Lauren, Ellis Justine, Wang Erica, Walter Vonn, Owens Russell G, Zaleski Michael, Warrick Joshua I, Raman Jay D, DeGraff David J

机构信息

Department of Pathology, Pennsylvania State University College of Medicine Hershey, PA, USA.

Department of Public Health Sciences, Pennsylvania State University College of Medicine Hershey, PA, USA.

出版信息

Am J Clin Exp Urol. 2019 Jun 15;7(3):139-152. eCollection 2019.

PMID:31317053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6627545/
Abstract

BACKGROUND

Creation of genetically engineered mouse models of bladder cancer often involves the use of several background strains in conjunction with the carcinogen N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN). However, carcinogen susceptibility in commonly used strains, as well as phenotypic differences is not well characterized.

OBJECTIVES

To determine differences in susceptibility and phenotypic outcome following BBN exposure of C57BL/6 and FVB, two strains commonly used for model development.

METHODS

Male C57BL/6 and FVB mice were exposed to BBN (0.05%) in drinking water for 12 and 16 weeks. Dissected bladders were characterized by histological and immunohistochemical analyses. Gene Ontology analysis was performed to identify differences in gene expression across strains following BBN exposure.

RESULTS

While the C57BL/6 strain developed non-invasive tumors, FVB mice developed muscle invasive bladder cancer with squamous and/or glandular differentiation. Glandular differentiation was exclusively observed in the FVB strain. FVB tumors were highly immunogenic and inflamed by the presence of high expression of Cd274 (Pdl-1), murine histocompatibility complex (H2) and pro-inflammatory cytokines (Il-5 and Il-17).

CONCLUSIONS

Following BBN exposure, FVB mice undergo rapid tumorigenesis and disease progression characterized by Pdl-1 expression and development of glandular differentiation. These studies identify a degree of tumor heterogeneity in the FVB tumors previously undescribed, and identify FVB mice as a potentially useful model for the study of bladder adenocarcinoma and the inflammatory tumor microenvironment.

摘要

背景

创建膀胱癌基因工程小鼠模型通常涉及使用几种背景品系并结合致癌物N-丁基-N-(4-羟基丁基)亚硝胺(BBN)。然而,常用品系对致癌物的易感性以及表型差异尚未得到充分表征。

目的

确定常用于模型开发的C57BL/6和FVB这两种品系在接触BBN后易感性和表型结果的差异。

方法

将雄性C57BL/6和FVB小鼠暴露于含0.05%BBN的饮用水中12周和16周。对解剖后的膀胱进行组织学和免疫组织化学分析。进行基因本体分析以确定BBN暴露后各品系间基因表达的差异。

结果

C57BL/6品系发展为非侵袭性肿瘤,而FVB小鼠发展为具有鳞状和/或腺性分化的肌肉侵袭性膀胱癌。仅在FVB品系中观察到腺性分化。FVB肿瘤具有高度免疫原性,且因Cd274(Pdl-1)、小鼠组织相容性复合体(H2)和促炎细胞因子(Il-5和Il-17)的高表达而发炎。

结论

接触BBN后,FVB小鼠经历快速肿瘤发生和疾病进展,其特征为Pdl-1表达和腺性分化的发展。这些研究确定了FVB肿瘤中以前未描述的一定程度的肿瘤异质性,并确定FVB小鼠是研究膀胱腺癌和炎性肿瘤微环境的潜在有用模型。